Zobrazeno 1 - 10
of 1 825
pro vyhledávání: '"Komrokji RS"'
Autor:
Montoro MJ; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Palomo L; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Acha P; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain., Chan O; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Navarro V; Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Kubota Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Schulz FI; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, University Hospital of Düsseldorf, Düsseldorf, Germany., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Briski R; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Al Ali N; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Xicoy B; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain., López-Cadenas F; Department of Hematology, Hospital del Mar, Barcelona, Spain., Bosch F; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain., González T; Department of Hematology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Eder LN; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Georg August University, Göttingen, Germany., Jerez A; Department of Hematology, Hospital Morales Meseguer, Murcia, Spain., Wang YH; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, United Kingdom., Campagna A; Department of Biomedical Sciences, Humanitas Clinical and Research Center-IRCCS and Humanitas University, Milan, Italy., Santini V; Hematology, MDS Unit, University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Bernal Del Castillo T; Department of Hematology, Servicio de Hematología, Hospital Universitario Central de Asturias Instituto de Investigación del Principado de Asturias, Oviedo, Spain., Such E; Department of Hematology, Servicio de Hematología, Hospital La Fe, Valencia, Spain., Tien HF; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Diaz Varela N; Department of Hematology, Servicio de Hematología, Hospital Universitario Central de Asturias Instituto de Investigación del Principado de Asturias, Oviedo, Spain., Platzbecker U; Department of Hematology, University Hospital of Leipzig, Dresden, Germany., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Georg August University, Göttingen, Germany., Díez-Campelo M; Department of Hematology, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain., Della Porta M; Department of Biomedical Sciences, Humanitas Clinical and Research Center-IRCCS and Humanitas University, Milan, Italy., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX., Wiseman DH; Division of Cancer Sciences, Epigenetics of Haematopoiesis Laboratory, The University of Manchester, Manchester, United Kingdom., Germing U; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, University Hospital of Düsseldorf, Düsseldorf, Germany., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Sole F; MDS Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Valcárcel D; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Publikováno v:
Blood [Blood] 2024 Oct 17; Vol. 144 (16), pp. 1722-1731.
Autor:
Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lanino L; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Ball S; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marchetti M; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Maggioni G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Travaglino E; IRCCS Polilcinico San Matteo, Pavia, Italy., Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Fenaux P; Saint Louis Hospital, Paris Cité University, Paris, France., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Santini V; University of Florence, Florence, Italy., Diez-Campelo M; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Singh A; Cleveland Clinic, Cleveland, OH, USA., Jain AG; Cleveland Clinic, Cleveland, OH, USA., Aguirre LE; Dana Farber Cancer Institute, Boston, MA, USA., Tinsley-Vance SM; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Schwabkey ZI; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xie Z; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Brunner AM; Dana Farber Cancer Institute, Boston, MA, USA., Kuykendall AT; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Bennett JM; University of Rochester Medical Center, Rochester, NY, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bejar R; University of California San Diego, San Diego, CA, USA., Carraway HE; Cleveland Clinic, Cleveland, OH, USA., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Halene S; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Hasserjian RP; Massachusetts General Hospital, Boston, MA, USA., Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., List AF; Precision BioSciences, Durham, NC, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Roboz GJ; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA., Stahl M; Dana Farber Cancer Institute, Boston, MA, USA., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Steensma DP; Ajax Therapeutics, Cambridge, MA, USA., Savona MR; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Xu ML; Department of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Hourigan CS; Virginia Tech FBRI Cancer Research Center, Washington, DC, USA., Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sauta E; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., D'Amico S; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Train, Milan, Italy., Asti G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Delleani M; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Campagna A; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Borate UM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sanz G; Instituto de Salud Carlos III, Valencia, Spain., Efficace F; Department of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain., Gore SD; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Kim TK; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rozman M; Hospital Clínic Barcelona, Barcelona, Spain., Orfao A; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Foucar MK; University of New Mexico, Albuquerque, NM, USA., Germing U; Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Scheinberg P; Beneficência Portuguesa de São Paulo Hospital, São Paulo, Brazil., Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina., Kulasekararaj A; King's College Hospital NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK., Cluzeau T; Nice University Hospital, Nice, France., Kordasti S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, UK., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center-Cancer Center, Amsterdam, Netherlands., Ades L; Saint Louis Hospital, Paris Cité University, Paris, France., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Della Porta MG; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.eu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.
Autor:
Csizmar CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Gurney M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Chien K; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond D; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Finke CM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Dean C; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Natu A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Garcia-Manero G; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Ali NA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Montalban-Bravo G; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN. patnaik.mrinal@mayo.edu.
Publikováno v:
Haematologica [Haematologica] 2024 Oct 01; Vol. 109 (10), pp. 3419-3425. Date of Electronic Publication: 2024 Oct 01.
Autor:
Aakash F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gisriel SD; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA., Bennett JM; James P Wilmot Cancer Center and Division of Hematopathology, University of Rochester Medical Center, Rochester, NY, USA., Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Borate UM; Division of Haematology, the Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Boultwood J; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Brunner AM; Division of Haematology, Massachusetts General Hospital Brigham, Boston, MA, USA., Buckstein R; Department of Medical Oncology/ Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Carraway H; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Churpek JE; Department of Haematology, Oncology, and Palliative Care, Carbone Cancer Center, The University of Wisconsin-Madison, Madison, WI., Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD, USA., Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit, Rome, Italy., Fenaux P; Service d'hématologie, Hôpital Saint-Louis (Assistance Publique Hôpitaux de Paris) and Université de Paris-Cité, Paris, France., Figueroa ME; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gore SD; National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD, USA., Greenberg PL; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA., Hourigan CS; Virginia Tech, Fralin Biomedical Research Institute, Cancer Research Center., Kim TK; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Kim N; NCI, NIH, Bethesda, Maryland., Komrokji RS; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kutchroo V; Brigham and Women's Hospital, Boston, MA, USA., List AF; Precision BioSciences, Inc., Durham, NC, USA., Little RF; National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD, USA., Majeti R; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Nazha A; Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Nimer SD; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Platzbecker U; Department of Haematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Della Porta MG; IRCCS Humanitas Research Hospital, Milan, Italy and Department of Biomedical Sciences, Humanitas University, Milan, Italy., Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY, USA., Sallman DA; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Santini V; Myelodysplastic syndromes Unit, Department of Experimental and Clinical Medicine, Haematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., Sanz G; Health Research Institute La Fe, Valencia, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain; CIBERONC, IS Carlos III, Madrid, Spain., Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Sekeres MA; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Stahl M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Starczynowski DT; Cincinnati Children's Hospital, Cincinnati, OH., Steensma DP; David Steensma LLC, Cambridge, Massachusetts 02139, USA., Taylor J; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wei AH; Department of Haematology, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research and University of Melbourne, Victoria, Australia., Zhuoer X; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xu ML; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Hasserjian RP; Department of Pathology, Massachusetts General Hospital Brigham, Boston, MA, USA., Loghavi S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: Sloghavi@mdanderson.org.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Sep 23, pp. 100615. Date of Electronic Publication: 2024 Sep 23.
Autor:
Della Porta MG; Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.edu., Garcia-Manero G; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Santini V; MDS Unit, Hematology, University of Florence, DMSC, AOUC, Florence, Italy., Zeidan AM; Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT, USA., Komrokji RS; Moffitt Cancer Center, Tampa, FL, USA., Shortt J; Monash University and Monash Health, Melbourne, VIC, Australia., Valcárcel D; Vall Hebron Institute of Oncology (VHIO), Hematology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Jonasova A; Medical Department, Hematology, Charles University General Hospital, Prague, Czech Republic., Dimicoli-Salazar S; Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Tiong IS; Malignant Haematology & Stem Cell Transplantation, The Alfred, Melbourne, VIC, Australia; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Lin CC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan., Li J; Bristol Myers Squibb, Princeton, NJ, USA., Zhang J; Bristol Myers Squibb, Princeton, NJ, USA., Pilot R; Bristol Myers Squibb, Princeton, NJ, USA., Kreitz S; Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland., Pozharskaya V; Bristol Myers Squibb, Princeton, NJ, USA., Keeperman KL; Bristol Myers Squibb, Princeton, NJ, USA., Rose S; Bristol Myers Squibb, Princeton, NJ, USA., Prebet T; Bristol Myers Squibb, Princeton, NJ, USA., Lai Y; Bristol Myers Squibb, Princeton, NJ, USA., Degulys A; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Paolini S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Cluzeau T; Département d'Hématologie Clinique, Université Cote d'Azur, CHU Nice, Nice, France., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France., Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Sep; Vol. 11 (9), pp. e646-e658. Date of Electronic Publication: 2024 Jul 19.
Autor:
Xie Z; Moffitt Cancer Center, Tampa, Florida, United States., Komrokji RS; H. Lee Moffitt Cancer Center, Tampa, Florida, United States., Al-Ali N; H. Lee Moffitt Cancer Center, Tampa, Florida, United States., Regelson A; Mayo Clinic, Rochester, Minnesota, United States., Geyer S; Mayo Clinic, Rochester, Minnesota, United States., Patel AA; University of Chicago, Chicago, Illinois, United States., Saygin C; Section of Hematology/Oncology, The University of Chicago, Chicago, IL, Chicago, Illinois, United States., Zeidan AM; Yale University, New Haven, Connecticut, United States., Bewersdorf JP; Yale School of MedicineUniversity, New Haven, Connecticut, United States., Mendez LM; Yale University School of Medicine, New Haven, Connecticut, United States., Kishtagari A; Vanderbilt University Medical Center, Nashville, Tennessee, United States., Zeidner JF; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States., Coombs CC; University of California Irvine, San Diego, California, United States., Madanat YF; UT Southwestern Medical Center, Dallas, Texas, United States., Chung SS; University of Texas Southwestern, Dallas, Texas, United States., Badar T; Mayo Clinic, Jacksonville, Florida, United States., Foran JM; Mayo Clinic Florida, Jacksonville, Florida, United States., Desai P; Weill Cornell Medicine, New York, New York, United States., Tsai C; Weill Cornell Medicine, New York, New York, United States., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States., Al Malki MM; City of Hope National Medical Center, Duarte, California, United States., Amanam I; City of Hope National Medical Center, Duarte, California, United States., Lai C; University of Pennsylvania, Philidelphia, Pennsylvania, United States., Deeg HJ; Fred Hutchinson Cancer Center, Seattle, Washington, United States., Ades L; Hopital Saint Louis, Paris, France., Arana-Yi C; Mayo Clinic, Phoenix, Arizona, United States., Osman AE; The University of Utah, Salt Lake city, Utah, United States., Dinner SN; Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, United States., Abaza Y; Northwestern University, Chicago, Illinois, United States., Taylor J; University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States., Chandhok NS; University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida, United States., Soong D; University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States., Brunner AM; Massachusetts General Hospital, Boston, Massachusetts, United States., Carraway HE; Cleveland Clinic, Cleveland, Ohio, United States., Singh A, Elena C; IRCCS Fondazione Policlinico San Matteo, Pavia, Tennessee, Italy., Ferrari J; University of Pavia & Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy, Pavia, Italy., Galli A; Fondazione IRCCS Policlinico San Matteo, pavia, Italy., Pozzi S; University of Pavia, Pavia, Italy, Pavia, Italy., Padron E; H. Lee Moffitt Cancer Center, Tampa, Florida, United States., Patnaik MM; Mayo Clinic, Rochester, Minnesota, United States., Malcovati L; University of Pavia, Pavia, Italy., Savona MR; Vanderbilt University School of Medicine, Nashville, Tennessee, United States., Al-Kali A; Mayo Clinic, Rochester, Minnesota, United States.
Publikováno v:
Blood [Blood] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12.
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.
Autor:
Vincelette ND; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Yu X; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida., Kuykendall AT; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Moon J; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Su S; Department of Chemistry, University of Illinois Chicago, Chicago, Illinois., Cheng CH; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida., Sammut R; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida.; Département d'Hématologie Clinique, Centre Hospitalier Universitaire de Nice, Nice, France., Razabdouski TN; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Nguyen HV; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Eksioglu EA; Department of Immunology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Chan O; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Al Ali N; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Patel PC; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida.; Department of Internal Medicine, University of South Florida, Tampa, Florida., Lee DH; Division of Cardiovascular Science, Department of Internal Medicine, University of South Florida, Tampa, Florida., Nakanishi S; Department of Tumor Microenvironment & Metastasis, Moffitt Cancer Center & Research Institute, Tampa, Florida., Ferreira RB; Department of Drug Discovery, Moffitt Cancer Center & Research Institute, Tampa, Florida., Hyjek E; Department of Pathology and Laboratory Medicine, Moffitt Cancer Center & Research Institute, Tampa, Florida., Mo Q; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida., Cory S; The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Lawrence HR; Department of Drug Discovery, Moffitt Cancer Center & Research Institute, Tampa, Florida., Zhang L; Department of Pathology and Laboratory Medicine, Moffitt Cancer Center & Research Institute, Tampa, Florida., Murphy DJ; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Cancer Research UK Scotland Institute, Glasgow, United Kingdom., Komrokji RS; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Lee D; Department of Chemistry, University of Illinois Chicago, Chicago, Illinois., Kaufmann SH; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Cleveland JL; Department of Tumor Microenvironment & Metastasis, Moffitt Cancer Center & Research Institute, Tampa, Florida., Yun S; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2024 Jul 01; Vol. 5 (4), pp. 276-297.
Autor:
Ionescu F; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL., David JC; Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, FL., Ravichandran A; University of South Florida/Morsani School of Medicine, Tampa, FL., Sallman DA; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL., Sweet K; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL., Komrokji RS; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL., Chan O; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL., Kuykendall A; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL., Padron E; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL., Faramand R; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL., Bejanyan N; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL., Khimani F; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL., Elmariah H; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL., Pidala J; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL., Mishra A; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL., Perez L; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL., Nishihori T; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL., Lancet JE; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address: jeffrey.lancet@moffitt.org.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Jun; Vol. 24 (6), pp. 400-406. Date of Electronic Publication: 2024 Feb 12.
Autor:
Platzbecker U; Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany. uwe.platzbecker@medizin.uni-leipzig.de., Santini V; MDS Unit, AOU Careggi, University of Florence, Florence, Italy., Komrokji RS; Moffitt Cancer Center, Tampa, FL, USA., Zeidan AM; Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Miteva D; Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland., Keeperman K; Bristol Myers Squibb, Princeton, NJ, USA., Holot N; Bristol Myers Squibb, Princeton, NJ, USA., Nadal JA; Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland., Lai Y; Bristol Myers Squibb, Princeton, NJ, USA., Vodala S; Bristol Myers Squibb, Princeton, NJ, USA., Rosettani B; Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland., Giuseppi AC; Bristol Myers Squibb, Princeton, NJ, USA., Yucel A; Bristol Myers Squibb, Princeton, NJ, USA., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris, France.
Publikováno v:
Leukemia [Leukemia] 2023 Nov; Vol. 37 (11), pp. 2314-2318. Date of Electronic Publication: 2023 Sep 26.
Autor:
Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. amer.zeidan@yale.edu., Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Steensma DP; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Platzbecker U; Leipzig University Hospital, Leipzig, Germany., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Boultwood J; Blood Cancer UK Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Bennett JM; Hematopathology Division, Departments of Pathology and Medicine, University of Rochester Medical Center, Rochester, NY, USA., Borate U; Division of Hematology, Department of Internal Medicine, James Cancer Center, Ohio State University, Columbus, OH, USA., Brunner AM; Leukemia Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Carraway H; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Churpek JE; Department of Hematology, Oncology, and Palliative Care, Carbone Cancer Center, The University of Wisconsin-Madison, Madison, WI, USA., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Della Porta M; Department of Biomedical Sciences, Humanitas Clinical and Research Center & Humanitas University, Milan, Italy., DeZern AE; Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre, Baltimore, MD, USA., Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy., Fenaux P; Hôpital Saint Louis, Paris, France., Figueroa ME; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Greenberg P; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Kim N; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kim TK; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Kutchroo V; Evergrande Center for Immunologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA., List AF; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Majeti R; Division of Hematology, Department of Medicine, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA., Nazha A; Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Odenike O; The University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Roboz GJ; Weill Cornell Medical College, New York, NY, USA., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Sanz G; Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain; Health Research Institute La Fe, Valencia, Spain; and CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Stahl M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Starczynowski DT; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Xie Z; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Xu M; Departments of Pathology & Laboratory Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA., Savona MR; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Wei AH; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne and Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Santini V; University of Florence Medical School, Florence, Italy.
Publikováno v:
Leukemia [Leukemia] 2022 Dec; Vol. 36 (12), pp. 2939-2946. Date of Electronic Publication: 2022 Oct 20.